Virpax Pharmaceuticals Reports 2022 Third Quarter Results

–Company Highlights Development Timelines for Product Candidates– BERWYN, Pa.–(BUSINESS WIRE)–#earnings–Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX) a company specializing in developing non-addictive product candidates for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and viral barrier indications, today announced its financial results for the quarter ended September 30, 2022, and other recent … [Read more…]

Saranas Announces Over 1,200 Patients Treated with the Early Bird® Bleed Monitoring System

HOUSTON–(BUSINESS WIRE)–Saranas, Inc. announced today that over 1,200 patients have been treated with the Early Bird® Bleed Monitoring System, the first and only FDA-approved bleed detection system. The Early Bird was launched in 2019 following a De Novo classification by the U.S. Food and Drug Administration. The device monitors and detects endovascular bleed complications through … [Read more…]

Health Systems Collaborate With NAHQ to Standardize Competencies

Three quality-driven organizations adopt NAHQ’s standard framework workforce solution for quality and safety. CHICAGO–(BUSINESS WIRE)–#HealthcareQuality–Standardizing competencies across roles and responsibilities in healthcare and upskilling the workforce is a vital solution to reducing variability in care delivery and ultimately making healthcare better. The National Association for Healthcare Quality® (NAHQ) is pleased to announce that Texas-based CHRISTUS … [Read more…]

Keystone Bio Adds Significant Scientific Leadership with Appointment of Medical Advisor and New Scientific Advisory Board Members

Michael Rafii, M.D., Ph.D., joins leadership team as Senior Medical Advisor, Neurology Company announces SAB with members’ deep expertise in neurological and cardio-metabolic diseases ST. LOUIS–(BUSINESS WIRE)–Keystone Bio, a clinical-stage biotechnology company working to stop inflammatory-based disease at its source, announced today the appointment of Michael Rafii, M.D., Ph.D., as Senior Medical Advisor in Neurology. … [Read more…]

Precision Biologics To Deliver Poster Presentations On Clinical And Scientific Programs At Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting

BETHESDA, Md.–(BUSINESS WIRE)–Precision Biologics, Inc. (“Precision”), a clinical-stage immunotherapy and targeted oncology company, will present at the SITC 37th Annual Meeting (2022) in Boston, MA. The first poster presentation will discuss the novel target for its NEO-201 monoclonal antibody and mechanism of action for this drug including the specific O-glycan epitope recognized by NEO-201 and … [Read more…]

Veradigm EHR Achieves 2015 ONC Health IT Update Certification

Supporting healthcare practices to successfully meet federal reporting requirements CHICAGO–(BUSINESS WIRE)–$MDRX #healthIT–Veradigm, a business unit of Allscripts (NASDAQ: MDRX), announced today that Veradigm EHR (formerly known as Professional EHR) has achieved 2015 ONC Health IT Update Certification. The Office of the National Coordinator for Health Information Technology (ONC) Health IT Certification Program (Certification Program) ensures … [Read more…]

Elevance Health to Acquire BioPlus

Acquisition deepens Elevance Health’s capabilities in specialty pharmacy INDIANAPOLIS–(BUSINESS WIRE)–$ELV–Elevance Health (NYSE: ELV) today announced that it has entered into an agreement with CarepathRx, a portfolio company of Nautic Partners, to acquire BioPlus, a comprehensive specialty pharmacy. BioPlus provides a complete range of specialty pharmacy services for patients living with complex and chronic conditions, such … [Read more…]

Rapid ICH Receives New FDA Clearance with Highest Sensitivity and Specificity on the Market

New version of ICH reduces notification fatigue with a near perfect false positive rejection rate; and allows medical teams to make faster decisions for improved hemorrhage management SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the global leader in neurovascular and vascular AI-enhanced clinical decision support and patient workflow, today announced it has received FDA 510(k) clearance for the … [Read more…]

Vertex to Participate in Upcoming Investor Conferences

BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced its participation in the following upcoming investor conferences: Jefferies London Healthcare Conference on Wednesday, November 16, 2022, at 9:10 a.m. GMT (4:10 a.m. EST) 5th Annual Evercore ISI HealthCONx Conference on Wednesday, November 30, 2022, at 9:15 a.m. EST A live webcast of management’s remarks will be … [Read more…]

Alnylam to Webcast Presentations at Upcoming November Investor Conferences

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present company overviews at the following conferences: Jefferies London Healthcare Conference on Wednesday, November 16, 2022 at 2:05 pm GMT (9:05 am ET) at the Waldorf Hilton in London Stifel 2022 Healthcare Conference on Wednesday, November 16, 2022 … [Read more…]